Injection Lipolysis Market

The Injection Lipolysis Market is valued at USD 1.33 Bn in 2026 and is projected to reach USD 1.8 Bn, growing at a CAGR of 4% by 2033.

Increasing Prevalence of Obesity Bodes Well for Injection Lipolysis Market

The global injection lipolysis market is anticipated to exhibit significant growth because of the rising prevalence of obesity and awareness of fat reduction techniques among obese people. By utilizing chemicals (deoxycholic acid, and phosphatidylcholine), injectable lipolysis decreases the number of fat cells at the injection site. This causes fat cells to be disrupted and eventually die. Body shaping techniques like injection lipolysis are not meant to treat obesity. The key factors driving the growth of injection lipolysis market include expanding acceptance and demand for body contouring treatments, increased healthcare spending, and an increase in the prevalence of obesity. The global injection lipolysis market is anticipated to experience significant growth because of the rising prevalence of obesity, and awareness of fat reduction techniques among obese people. With rising inclination toward minimally invasive techniques, lipotherapy or injection lipolysis is likely to witness mounting demand. In 2019, Americans had 16.65 trillion dollars in disposable personal income, or US$43,828 per person, according to the US Bureau of Economic Analysis. People have more money to spend on their bills. They are more likely to choose an aesthetic surgery.

The market landscape will be strengthened by ongoing equipment technology developments and several surgical and non-surgical boy fat reduction techniques. Additionally, there is a sizable presence of various well-established local market competitors who are consistently creating revolutionary gadgets using cutting-edge techniques like radiofrequency laser lipolysis and light treatment, among others. The limited supply of injection lipolysis medications presents a significant potential for the major participants in injection lipolysis market to develop and introduce new medications with improved therapeutic outcomes and minimal side effects during the forecasted periods. The market expansion for injection lipolysis is projected to be constrained by safety concerns over some of the negative effects of the procedure. VLCC Wellness partnered with Minor Hotels in October 2019 to grow its therapeutic wellness and beauty centers. The business potential of the company has grown thanks to this strategy.

Injection Lipolysis Market: COVID-19 Impact

Due to postponed aesthetic operations in 2020, the COVID-19 epidemic has negatively influenced the demand for body fat reduction products. Overall market demand has been hampered by the implementation of preventative lockdowns in some economies, movement limitations, stringent rules, and guidelines for accessing clinical services. Additionally, a considerable decrease in patient interest in aesthetic operations due to increased worries about the COVID-19 virus and safety limited the number of body fat reduction surgeries performed in the early phases of the pandemic. But in 2021, the injection lipolysis market witnessed an increase in cosmetic procedures, indicating a bright future for the sector.

Growing Preference for Non-invasive Body Fat Reduction Fuels Injection Lipolysis Market Growth

The market landscape will be strengthened by ongoing equipment technology developments and several surgical and non-surgical boy fat reduction techniques. Additionally, there is a sizable presence of various well-established local market competitors who are consistently creating revolutionary gadgets using cutting-edge techniques like radiofrequency laser lipolysis and light treatment, among others. The market now offers a wide range of non-invasive red light therapy devices for body fat reduction, including the Nushape Lipo Wrap by Nutshell, the EMS LED Light fat burning belt, the 635/850nm Red Light Therapy Arm Belt by ZorMu, and the Joovv Solo 3.0 Full Body Panel. The market size is projected to increase as these gadgets are widely adopted. Additionally, non-invasive and minimally invasive methods offer long-lasting fat cell destruction and quicker results in less time. Over the expected timeframe, the factors above will boost demand for the injection lipolysis market.

Potential Side-effects May Remain the Key Impediment Facing Injection Lipolysis Market

The injection lipolysis market is projected to be constrained by safety concerns over some of the negative effects of the procedure. This mixture to battle obesity can strain the kidneys if you aren't drinking enough water. This strain may cause urinary issues as well as stomach-ache. Lipotropic injections can help shed weight and fat by altering your digestive system. Your body is working harder than usual by speeding up your metabolism and digestive system. In the period right after the injection, this increased workload may cause acute tiredness. Through a needle, lipotropic injections are administered into the body, and the injection site can become painful or uncomfortable after that.

Hospitals Continue to Register the Maximum Adoption Rate in Injection Lipolysis Market

The injection lipolysis market is divided into clinics, hospitals, and medical spas depending on the service provider. The market share of hospitals, around 54% in 2021, is expected to increase significantly throughout the projected period. The significant spike is mostly due to an increased number of patients admitted for aesthetic operations. The segmental expansion would be fuelled by rising demand for various surgical treatments like abdominoplasty and liposuction for body fat reduction. The patient volume will increase in the coming years due to sophisticated infrastructure, technologically advanced equipment integration, procedural knowledge availability, and a wide range of operations.

Higher Adoption of Abdominoplasty by Female Population Bolsters the Growth of Injection Lipolysis Market

The injection lipolysis market is divided into surgical and non-surgical categories based on the procedure. The surgical procedures segment is further separated into abdominoplasty and liposuction. In 2021, the abdominoplasty sector accounted for more than 40% share in the injection lipolysis market. Tummy tucks, commonly referred to as abdominoplasty, are performed to remove excess body fat from the abdomen. Women frequently use these techniques, especially after giving birth, to eliminate excess fat that they cannot properly reduce without surgery. To accomplish weight loss, the widespread use of stomach tuck procedures in several nations may further influence the market forecast.

Higher R&D Investments Continue to Uphold North America’s Dominant Position in Injection Lipolysis Market

With a 35.9% revenue share in the injection lipolysis market in 2021, North America dominated the non-invasive fat reduction market, and this trend is anticipated to last throughout the forecast period. The International Society of Aesthetic Plastic Surgery reports that 3,182,815 treatments were performed in the United States in 2020, making it the nation with the most nonsurgical operations. The rise in the number of obese people, the expansion of R&D in the area, the greatest per capita disposable income, the increased uptake of new technology, and ongoing awareness programs may all be contributed to this. The growth of injection lipolysis market in the region is driven by the rising demand for a flawless look and confidence via physical traits in the main domains of work. The country's non-invasive fat reduction market is being fuelled by the development of practical methods and simple access to healthcare facilities. Over the projection period, injection lipolysis market in Asia Pacific is anticipated to experience the greatest CAGR. This is ascribed to several factors, including cheap treatment costs, growing patient knowledge of the advantages of body contouring procedures, increased demand for aesthetic procedures, the cultural embrace of western economies, and marketing tactics used by the major market competitors. The sum of these elements will cause the Asia Pacific region to stand out as the most promising, fast-growing market over the projection period.

Injection Lipolysis Market: Competitive Landscape

Erchonia's Zerona Z6 body contouring devices, which offer full-body fat removal treatment, were acquired by Lindora in October 2019. The company's body fat reduction services on the west coast have grown. VLCC Wellness partnered with Minor Hotels in October 2019 to grow its therapeutic wellness and beauty centers. The business potential of the company has grown thanks to this strategy.

A few of the injection lipolysis market players include:

• Allergan (AbbVie)
• Cynosure (Hologic)
• Galderma
• Merz Aesthetics
• SBC Aesthetic
• Suneva Medical
• Dermatech Corporation
• Teoxane Laboratories
• Biotech Pharma Group
• Sculpture Aesthetic
• Lumenis
• BTL Aesthetics
• InMode (Alma Lasers)
• Cutera, Inc.
• Revanesse (Prollenium Medical)

The Global Injection Lipolysis Market is Segmented as Below:

By Drug Type
• Deoxycholic Acid
• Phosphatidylcholine
• Others

By Treatment Site
• Facial Fat Deposits
• Submental Fat
• Upper Arm Fat
• Abdominal Fat
• Thighs Fat
• Knee Fat
• Buttock Fat
• Others

By End-user
• Hospitals
• Dermatology and Cosmetic Clinics
• Ambulatory Surgical Centers

By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East and Africa